Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueTax ProvisionsTax Rate
Others
Ratios

Healthstream (HSTM) EBITDA (2016 - 2025)

Historic EBITDA for Healthstream (HSTM) over the last 17 years, with Q3 2025 value amounting to $7.6 million.

  • Healthstream's EBITDA rose 1645.12% to $7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.5 million, marking a year-over-year increase of 799.41%. This contributed to the annual value of $25.1 million for FY2024, which is 2407.64% up from last year.
  • Latest data reveals that Healthstream reported EBITDA of $7.6 million as of Q3 2025, which was up 1645.12% from $5.9 million recorded in Q2 2025.
  • Healthstream's EBITDA's 5-year high stood at $7.6 million during Q3 2025, with a 5-year trough of -$460000.0 in Q4 2021.
  • In the last 5 years, Healthstream's EBITDA had a median value of $4.0 million in 2022 and averaged $4.0 million.
  • Its EBITDA has fluctuated over the past 5 years, first crashed by 14045.73% in 2021, then skyrocketed by 76891.3% in 2022.
  • Quarter analysis of 5 years shows Healthstream's EBITDA stood at -$460000.0 in 2021, then surged by 768.91% to $3.1 million in 2022, then soared by 38.25% to $4.3 million in 2023, then rose by 10.23% to $4.7 million in 2024, then soared by 61.38% to $7.6 million in 2025.
  • Its EBITDA was $7.6 million in Q3 2025, compared to $5.9 million in Q2 2025 and $4.4 million in Q1 2025.